https://www.cabalettabio.com/investors/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/cabalettabio/files/theme/images/logo-sm-new.png /investors Equisolve Investor Relations Suite https://www.cabalettabio.com/investors/news-events/press-releases/detail/146/cabaletta-bio-announces-pricing-of-150-million Mon, 04 May 26 06:35:00 -0400 https://www.cabalettabio.com/investors/news-events/press-releases/detail/146/cabaletta-bio-announces-pricing-of-150-million https://www.cabalettabio.com/investors/news-events/press-releases/detail/145/cabaletta-bio-and-cellares-announce-10-year-commercial Tue, 28 Apr 26 08:00:00 -0400 https://www.cabalettabio.com/investors/news-events/press-releases/detail/145/cabaletta-bio-and-cellares-announce-10-year-commercial https://www.cabalettabio.com/investors/news-events/press-releases/detail/144/cabaletta-bio-announces-multiple-upcoming-presentations Mon, 27 Apr 26 17:00:00 -0400 https://www.cabalettabio.com/investors/news-events/press-releases/detail/144/cabaletta-bio-announces-multiple-upcoming-presentations https://www.cabalettabio.com/investors/news-events/press-releases/detail/143/cabaletta-bio-reports-fourth-quarter-and-full-year-2025 Mon, 23 Mar 26 07:30:00 -0400 https://www.cabalettabio.com/investors/news-events/press-releases/detail/143/cabaletta-bio-reports-fourth-quarter-and-full-year-2025 https://www.cabalettabio.com/investors/news-events/press-releases/detail/142/cabaletta-bio-to-participate-in-the-td-cowen-46th-annual Tue, 24 Feb 26 08:00:00 -0500 https://www.cabalettabio.com/investors/news-events/press-releases/detail/142/cabaletta-bio-to-participate-in-the-td-cowen-46th-annual https://www.cabalettabio.com/investors/news-events/press-releases/detail/141/cabaletta-bio-to-participate-in-the-guggenheim-emerging Thu, 05 Feb 26 08:00:00 -0500 https://www.cabalettabio.com/investors/news-events/press-releases/detail/141/cabaletta-bio-to-participate-in-the-guggenheim-emerging https://www.cabalettabio.com/investors/news-events/press-releases/detail/140/cabaletta-bio-announces-2026-strategic-priorities Mon, 12 Jan 26 08:00:00 -0500 https://www.cabalettabio.com/investors/news-events/press-releases/detail/140/cabaletta-bio-announces-2026-strategic-priorities https://www.cabalettabio.com/investors/news-events/press-releases/detail/139/cabaletta-bio-reports-third-quarter-2025-financial-results Mon, 10 Nov 25 07:30:00 -0500 https://www.cabalettabio.com/investors/news-events/press-releases/detail/139/cabaletta-bio-reports-third-quarter-2025-financial-results https://www.cabalettabio.com/investors/news-events/press-releases/detail/138/cabaletta-bio-to-participate-in-upcoming-investor Tue, 04 Nov 25 08:00:00 -0500 https://www.cabalettabio.com/investors/news-events/press-releases/detail/138/cabaletta-bio-to-participate-in-upcoming-investor https://www.cabalettabio.com/investors/news-events/press-releases/detail/137/cabaletta-bio-presents-positive-clinical-data-and Mon, 27 Oct 25 07:00:00 -0400 https://www.cabalettabio.com/investors/news-events/press-releases/detail/137/cabaletta-bio-presents-positive-clinical-data-and